Natural Product: NPC485811

Natural Product IDNPC485811
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
SBUJHOSQTJFQJX-KSACQAOKSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 11274101
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000011] Carbohydrates and carbohydrate conjugates
          • [CHEMONTID:0003305] Aminosaccharides
            • [CHEMONTID:0000282] Aminoglycosides
              • [CHEMONTID:0001675] Aminocyclitol glycosides
                • [CHEMONTID:0003575] 2-deoxystreptamine aminoglycosides
                  • [CHEMONTID:0003574] 4,6-disubstituted 2-deoxystreptamines

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey SBUJHOSQTJFQJX-KSACQAOKSA-N
Standard InCHI InChI=1S/C18H36N4O11/c19-2-6-10(25)12(27)13(28)18(30-6)33-16-5(21)1-4(20)15(14(16)29)32-17-11(26)8(22)9(24)7(3-23)31-17/h4-18,23-29H,1-3,19-22H2/t4-,5+,6+,7-,8+,9-,10+,11-,12-,13+,14-,15+,16-,17-,18+/m1/s1
SMILES C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@H]1[C@H]([C@@H]([C@H]([C@H](CN)O1)O)O)O)O)O[C@@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)N)O)N

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   484.24 Volume:   434.894
?
Van der Waals volume.
Dense:   1.113 LogP:   -2.637
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   -1.727
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -0.22
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   6.0 Rigid Bonds:   18.0
TPSA:   282.61
?
Topological Polar Surface Area.
H-Bond Acceptor:   15.0
H-Bond Donor:   15.0 Rings:   3.0
Heavy Atoms:   15.0

MedChem Properties

QED Drug-Likeness Score:   0.167 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   5.052 Fsp3:   1.0
MCE-18:   69.333
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.638 Fluc inhibitor:   0.001
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.086
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.001
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.116 Promiscuous compounds:   0.002

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.115 MDCK Permeability:   -5.399
Pgp-inhibitor:   0.0 Pgp-substrate:   0.976
PAMPA:   1.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   1.0
20% Bioavailability (F20%):   0.926 30% Bioavailability (F30%):   0.999
50% Bioavailability (F50%):   0.992

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.001 MRP1:   0.033
Plasma Protein Binding (PPB):   13.528% Volume Distribution (VD):   -0.605
Fu: 82.366%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.996
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.0
BSEP inhibitor:   0.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.93 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.986 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.0
HLM stability:   0.0
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  0.926 Half-life (T1/2):  2.472

ADMET: Toxicity

hERG Blockers:  0.01 hERG Blockers (10um):  0.05
Human Hepatotoxicity (H-HT):  0.771 Drug-induced Liver Injury (DILI):  0.025
AMES Toxicity:  0.404 Rat Oral Acute Toxicity:  0.001
Maximum Recommended Daily Dose:  0.023 Skin Sensitization:  1.0
Carcinogencity:  0.005 Eye Corrosion:  0.0
Eye Irritation:  0.0 Respiratory Toxicity:  0.001
Drug-induced Neurotoxicity:  0.041 Ototoxicity:  1.0
Hematotoxicity:  0.125 Drug-induced Nephrotoxicity:  0.949
Genotoxicity:  0.034 RPMI-8226 Immunitoxicity:  0.255
A549 Cytotoxicity:  0.028 Hek293 Cytotoxicity:  0.003
BCF:   0.02
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   1.929
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   3.279
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   2.082
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO795 Streptomyces hawaiiensis Species Streptomycetaceae Bacteria n.a. n.a. n.a. PMID[25255326]
NPO795 Streptomyces hawaiiensis Species Streptomycetaceae Bacteria n.a. n.a. n.a. Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT317 Nucleic acid Nucleic Acid n.a. MIC > 100000.0 nM PMID[9457241]
NPT4383 Nucleic acid Ribosomal RNA A-site n.a. Kd = 18000.0 nM PMID[11206440]
NPT317 Nucleic acid Nucleic Acid n.a. Kd = 100.0 nM PMID[19445516]
NPT317 Nucleic acid Nucleic Acid n.a. EC50 = 300.0 nM PMID[19946275]
NPT317 Nucleic acid Nucleic Acid n.a. Activity = 25.0 % PMID[19946275]
NPT317 Nucleic acid Nucleic Acid n.a. Activity = 8.0 % PMID[19946275]
NPT317 Nucleic acid Nucleic Acid n.a. Activity = 69.6 % PMID[19946275]
NPT317 Nucleic acid Nucleic Acid n.a. Activity = 0.27 /s PMID[19946275]
NPT317 Nucleic acid Nucleic Acid n.a. Kd = 141000.0 nM PMID[22257890]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1118 Organism Streptococcus pneumoniae Streptococcus pneumoniae MIC = 8.0 ug.mL-1 PMID[20373816]
NPT1118 Organism Streptococcus pneumoniae Streptococcus pneumoniae MIC = 1.0 ug.mL-1 PMID[20373816]
NPT1033 Organism Enterobacter cloacae Enterobacter cloacae MIC = 4.0 ug.mL-1 PMID[107311]
NPT1033 Organism Enterobacter cloacae Enterobacter cloacae MIC > 125.0 ug.mL-1 PMID[107311]
NPT79 Organism Bacillus subtilis Bacillus subtilis Kd = 210000.0 nM PMID[15808490]
NPT173 Organism Klebsiella pneumoniae Klebsiella pneumoniae MIC = 64.0 ug.mL-1 PMID[21177112]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. MIC > 128.0 ug.mL-1 PMID[21177112]
NPT1466 Organism Escherichia coli K12 Escherichia coli K-12 MIC = 25.0 ug.mL-1 PMID[28018574]
NPT173 Organism Klebsiella pneumoniae Klebsiella pneumoniae MIC = 0.25 ug.mL-1 PMID[107311]
NPT2894 Organism Providencia rettgeri Providencia rettgeri MIC = 0.5 ug.mL-1 PMID[107311]
NPT2894 Organism Providencia rettgeri Providencia rettgeri MIC = 8.0 ug.mL-1 PMID[107311]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC = 256.0 ug.mL-1 PMID[17088479]
NPT19 Organism Escherichia coli Escherichia coli MIC = 12.0 ug.mL-1 PMID[17088479]
NPT19 Organism Escherichia coli Escherichia coli MIC = 768.0 ug.mL-1 PMID[17088479]
NPT19 Organism Escherichia coli Escherichia coli MIC = 125.0 ug.mL-1 PMID[19012394]
NPT19 Organism Escherichia coli Escherichia coli MIC = 32.0 ug.mL-1 PMID[19012394]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 4.0 ug.mL-1 PMID[20373816]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC > 512.0 ug.mL-1 PMID[20373816]
NPT17 Organism Staphylococcus epidermidis Staphylococcus epidermidis MIC = 2.0 ug.mL-1 PMID[20373816]
NPT17 Organism Staphylococcus epidermidis Staphylococcus epidermidis MIC = 128.0 ug.mL-1 PMID[20373816]
NPT19 Organism Escherichia coli Escherichia coli MIC = 8.0 ug.mL-1 PMID[20373816]
NPT19 Organism Escherichia coli Escherichia coli MIC = 16.0 ug.mL-1 PMID[20373816]
NPT19 Organism Escherichia coli Escherichia coli MIC = 32.0 ug.mL-1 PMID[20373816]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC > 512.0 ug.mL-1 PMID[20373816]
NPT1521 Organism Stenotrophomonas maltophilia Stenotrophomonas maltophilia MIC > 512.0 ug.mL-1 PMID[20373816]
NPT19 Organism Escherichia coli Escherichia coli Activity = 10.0 % PMID[19946275]
NPT19 Organism Escherichia coli Escherichia coli MIC = 256.0 ug.mL-1 PMID[20145089]
NPT19 Organism Escherichia coli Escherichia coli MIC = 2.0 ug.mL-1 PMID[20145089]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC = 1600.0 ug.mL-1 PMID[18285485]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC = 1920.0 ug.mL-1 PMID[18285485]
NPT19 Organism Escherichia coli Escherichia coli MIC = 2.0 ug.mL-1 PMID[21177112]
NPT19 Organism Escherichia coli Escherichia coli MIC = 4.0 ug.mL-1 PMID[21177112]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 2.0 ug.mL-1 PMID[21177112]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 128.0 ug.mL-1 PMID[21177112]
NPT17 Organism Staphylococcus epidermidis Staphylococcus epidermidis MIC = 1.0 ug.mL-1 PMID[21177112]
NPT17 Organism Staphylococcus epidermidis Staphylococcus epidermidis MIC = 8.0 ug.mL-1 PMID[21177112]
NPT17 Organism Staphylococcus epidermidis Staphylococcus epidermidis MIC > 128.0 ug.mL-1 PMID[21177112]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC > 128.0 ug.mL-1 PMID[21177112]
NPT175 Organism Enterococcus faecalis Enterococcus faecalis MIC = 64.0 ug.mL-1 PMID[21177112]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC > 100.0 ug.mL-1 PMID[28018574]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 1.0 ug.mL-1 PMID[107311]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC > 125.0 ug.mL-1 PMID[107311]
NPT19 Organism Escherichia coli Escherichia coli MIC = 4.0 ug.mL-1 PMID[107311]
NPT19 Organism Escherichia coli Escherichia coli MIC > 125.0 ug.mL-1 PMID[107311]
NPT19 Organism Escherichia coli Escherichia coli MIC = 125.0 ug.mL-1 PMID[107311]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC = 63.0 ug.mL-1 PMID[107311]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC = 32.0 ug.mL-1 PMID[107311]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC > 125.0 ug.mL-1 PMID[107311]
NPT2 Others Unspecified n.a. IC50 = 17800.0 nM PMID[12643896]
NPT2 Others Unspecified n.a. Inhibition = 61.0 % PMID[12643896]
NPT2 Others Unspecified n.a. IC50 = 24.0 nM PMID[12643896]
NPT2 Others Unspecified n.a. Inhibition = 92.0 % PMID[12643896]
NPT747 Organism Acinetobacter baumannii Acinetobacter baumannii MIC = 32.0 ug.mL-1 PMID[20373816]
NPT4815 Organism Neisseria meningitidis Neisseria meningitidis MIC = 64.0 ug.mL-1 PMID[25255326]
NPT1276 Organism Gibberella zeae Gibberella zeae MIC > 500.0 ug.mL-1 PMID[25110571]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC485811 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC43850
0.902 High Similarity NPC477060
0.7091 Intermediate Similarity NPC611754
0.65 Remote Similarity NPC607776
0.6491 Remote Similarity NPC314408
0.6176 Remote Similarity NPC330590
0.5902 Remote Similarity NPC605029

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC485811 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
1.0 High Similarity NPD3203 Phase 4
0.902 High Similarity NPD3201 Approved
0.7917 Intermediate Similarity NPD3200 Clinical (unspecified phase)
0.6491 Remote Similarity NPD3208 Phase 4
0.6491 Remote Similarity NPD3209 Approved
0.6176 Remote Similarity NPD5378 Phase 4
0.5968 Remote Similarity NPD3207 Approved
0.5833 Remote Similarity NPD5377 Approved

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data